Harmony Biosciences Harmony Biosciences develops therapies to help patients with unmet medical needs. | ![]() Lophius Biosciences Lophius Biosciences is a biotechnology company developing products for the diagnosis of acute infectious and autoimmune diseases. | ![]() Artax Biopharma Artax Biopharma is a biotechnology company that specializes in transforming autoimmune disease treatment. | ![]() Mesoblast Mesoblast specializes in the development of biologic products for the broad field of regenerative medicine. | Sanesco Sanesco Health International is a biomedical company providing healthcare practitioners with clinical tools and products used for neuroendocrine health. | |
Founding Date | Founding Date 2017 | Founding Date 2002 | Founding Date 2013 | Founding Date 2004 | Founding Date 2004 |
Type | Type Public | Type Private | Type Private | Type Public | Type Private |
Tags | |||||
Locations | Locations Plymouth Meeting, US HQ | Locations Regensburg, DE HQ | Locations Cambridge, US HQ | Locations Melbourne, AU HQ Singapore, SG New York, US | Locations Arden, US HQ |
Employees | Employees N/A | Employees 2 | Employees 14 | Employees 73 | Employees 23 |
Valuation ($) | Valuation ($) 2.4 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 1.2 b | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $714.7m (FY, 2024) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $5.9m (FY, 2024) | Revenue (est.) N/A |
Cost of goods | Cost of goods $156.8m (FY, 2024) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $557.9m (FY, 2024) | Gross profit N/A | Gross profit N/A | Gross profit $9.3m (FY, 2024) | Gross profit N/A |
Net income | Net income $145.5m (FY, 2024) | Net income N/A | Net income N/A | Net income ($88m) (FY, 2024) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 2.4m (over 8 years ago) | Latest funding round $ 26m (about 3 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 270m | Total funding raised $ 14.4m | Total funding raised $ 28m | Total funding raised $ 56.2m | Total funding raised N/A |
Lophius Biosciences is a biotechnology company developing products for the diagnosis of acute infectious and autoimmune diseases.
View companyArtax Biopharma is a biotechnology company that specializes in transforming autoimmune disease treatment.
View companyMesoblast specializes in the development of biologic products for the broad field of regenerative medicine.
View companySanesco Health International is a biomedical company providing healthcare practitioners with clinical tools and products used for neuroendocrine health.
View company